Preclinical Pharmacokinetics and Safety of Intravenous RTD-1

Severe illness caused by coronavirus disease 2019 (COVID-19) is characterized by an overexuberant inflammatory response resulting in acute respiratory distress syndrome (ARDS) and progressive respiratory failure (A. Gupta, M. V. Madhavan, K. Sehgal, N. Nair, et al., Nat Med 26:1017–1032, 2020, https...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, A. Young J., Tran, Dat Q., Schaal, Justin B., Wang, Mengxi, Selsted, Michael E., Beringer, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923172/
https://www.ncbi.nlm.nih.gov/pubmed/35041507
http://dx.doi.org/10.1128/aac.02125-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923172/
https://www.ncbi.nlm.nih.gov/pubmed/35041507
http://dx.doi.org/10.1128/aac.02125-21

Ejemplares similares